Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Inflammation and Fibrosis of Skeletal Muscles

Area of Science:

• Muscle physiology and regeneration
• Biochemistry of extracellular matrix remodeling
• Cellular and molecular biology of neuromuscular disorders

Background:

• Matrix MetalloProteinases (MMPs) and Tissue Inhibitors of MetalloProteinases (TIMPs) are crucial in skeletal muscle processes like myoblast migration and fusion.
• Dysregulation of MMPs/TIMPs is implicated in physiological and pathological muscle remodeling, including neuromuscular diseases.
• Inflammation and fibrosis in skeletal muscle present significant challenges for cell and gene therapy efficacy.

Purpose of the Study:

• To review the role of MMPs/TIMPs in skeletal muscle inflammation and fibrosis.
• To analyze the consequences of modulating MMP levels on skeletal muscle inflammation and repair.
• To discuss the interplay of MMPs/TIMPs with other factors contributing to fibrosis.

Main Methods:

• Literature review focusing on experimental findings regarding MMPs/TIMPs in skeletal muscle.
• Analysis of genetic and pharmacological modulation of MMP levels.
• Discussion of the relationship between MMPs/TIMPs, cytokines, growth factors, and inflammation in fibrosis.

Main Results:

• MMPs and TIMPs are involved in myoblast behavior and muscle remodeling.
• Modulation of MMPs can have beneficial, dual, or adverse effects on muscle morphology and function in disease models.
• The interplay between MMPs/TIMPs, inflammatory mediators, and growth factors promotes fibrosis.

Conclusions:

• MMPs/TIMPs play a complex role in skeletal muscle inflammation and fibrosis.
• Understanding MMP/TIMP dynamics is critical for improving cell and gene therapies for muscular dystrophies.
• Targeting MMPs/TIMPs offers potential therapeutic strategies for muscle repair and fibrosis resolution.